Cell Death and Fibrogenesis

Wajahat Mehal; Avlin Imaeda

doi:10.1055/s-0030-1255352

Seminars in Liver Disease, Table of Contents

Semin Liver Dis 2010; 30(3): 226-231
DOI: 10.1055/s-0030-1255352

Cell Death and Fibrogenesis

Wajahat Mehal¹ , Avlin Imaeda¹

¹Section of Digestive Diseases, Yale University, New Haven, Connecticut

Abstract

ABSTRACT

Fibrosis is a common feature of chronic liver injury and is initiated by cell death inside the liver. Hepatocyte death results in apoptotic bodies and other cellular debris, which are phagocytosed by hepatic stellate cells (HSCs), resulting in their activation, proliferation, differentiation, and matrix deposition. This profibrotic effect of cellular death is balanced by an antifibrotic effect of HSC death. Many HSC survival signals are obtained from the extracellular matrix, and active proapoptotic signals are provided by immune cells, particularly natural killer (NK) cells. Quiescent HSCs are relatively resistant to apoptotic signals but become sensitive after activation. The important role of NK cells in inducing HSC apoptosis may explain the increased fibrosis associated with immune suppression (e.g., in the transplant recipient) and HIV infection. HSCs also undergo senescence, which limits their function and sensitizes them to apoptosis.

KEYWORDS

Hepatic stellate cells - fibrosis - cell death - apoptosis

Full Text

References

REFERENCES

1 Friedman S L. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008; 134 1655-1669
2 Kroemer G, Galluzzi L, Vandenabeele P Nomenclature Committee on Cell Death 2009 et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009; 16 3-11
3 Kumar S. Caspase function in programmed cell death. Cell Death Differ. 2007; 14 32-43
4 Golstein P, Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem Sci. 2007; 32 37-43
5 Rautou P E, Cazals-Hatem D, Moreau R, Francoz C et al.. Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. Gastroenterology. 2008; 135 840-848
6 Canbay A, Feldstein A, Baskin-Bey E, Bronk S F, Gores G J. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther. 2004; 308 1191-1196
7 Walsh M J, Vanags D M, Clouston A D et al.. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology. 2004; 39 1230-1238
8 Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores G J. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest. 2003; 83 655-663
9 Zhan S S, Jiang J X, Wu J et al.. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology. 2006; 43 435-443
10 Jiang J X, Mikami K, Venugopal S, Li Y, Török N J. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. J Hepatol. 2009; 51 139-148
11 Jiang J X, Mikami K, Shah V H, Torok N J. Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase-dependent mechanism. Hepatology. 2008; 48 1497-1505
12 Muhanna N, Doron S, Wald O et al.. Activation of hepatic stellate cells after phagocytosis of lymphocytes: a novel pathway of fibrogenesis. Hepatology. 2008; 48 963-977
13 Kono H, Rock K L. How dying cells alert the immune system to danger. Nat Rev Immunol. 2008; 8 279-289
14 Watanabe A, Hashmi A, Gomes D A et al.. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology. 2007; 46 1509-1518
15 Sohail M A, Hashmi A Z, Hakim W et al.. Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology. 2009; 49 185-194
16 Hashmi A Z, Hakim W, Kruglov E A et al.. Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2007; 292 G395-G401
17 Chan E S, Montesinos M C, Fernandez P et al.. Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol. 2006; 148 1144-1155
18 Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009; 27 229-265
19 Watanabe A, Sohail M A, Gomes D A et al.. Inflammasome-mediated regulation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2009; 296 G1248-G1257
20 Kawada N. Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease. Gut. 2006; 55 1073-1074
21 Gong W, Pecci A, Roth S, Lahme B, Beato M, Gressner A M. Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology. 1998; 28 492-502
22 Cariers A, Reinehr R, Fischer R, Warskulat U, Häussinger D. c-Jun-N-terminal kinase dependent membrane targeting of CD95 in rat hepatic stellate cells. Cell Physiol Biochem. 2002; 12 179-186
23 Taimr P, Higuchi H, Kocova E, Rippe R A, Friedman S, Gores G J. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology. 2003; 37 87-95
24 Iredale J P, Benyon R C, Pickering J et al.. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998; 102 538-549
25 Duffield J S, Forbes S J, Constandinou C M et al.. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 2005; 115 56-65
26 Gao B, Radaeva S, Jeong W I. Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis. Expert Rev Gastroenterol Hepatol. 2007; 1 173-180
27 Vermijlen D, Luo D, Froelich C J et al.. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway. J Leukoc Biol. 2002; 72 668-676
28 Takeda K, Hayakawa Y, Smyth M J et al.. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med. 2001; 7 94-100
29 Laouar Y, Sutterwala F S, Gorelik L, Flavell R A. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol. 2005; 6 600-607
30 Trim N, Morgan S, Evans M et al.. Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am J Pathol. 2000; 156 1235-1243
31 Oakley F, Trim N, Constandinou C M et al.. Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. Am J Pathol. 2003; 163 1849-1858
32 Saile B, DiRocco P, Dudas J et al.. IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF). Lab Invest. 2004; 84 1037-1049
33 Issa R, Williams E, Trim N et al.. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut. 2001; 48 548-557
34 Saile B, Matthes N, Knittel T, Ramadori G. Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology. 1999; 30 196-202
35 Krizhanovsky V, Yon M, Dickins R A et al.. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134 657-667
36 Schrader J, Fallowfield J, Iredale J P. Senescence of activated stellate cells: not just early retirement. Hepatology. 2009; 49 1045-1047
37 Issa R, Zhou X, Trim N et al.. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J. 2003; 17 47-49
38 Issa R, Zhou X, Constandinou C M et al.. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology. 2004; 126 1795-1808
39 Elsharkawy A M, Oakley F, Mann D A. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis. 2005; 10 927-939
40 Saxena N K, Titus M A, Ding X et al.. Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J. 2004; 18 1612-1614
41 Wang J, Leclercq I, Brymora J M et al.. Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology. 2009; 137 713-723
42 Pinzani M. Unraveling the spider web of hepatic stellate cell apoptosis. Gastroenterology. 2009; 136 2061-2063
43 Oakley F, Teoh V, Ching A SG, Bataller R, Colmenero J, Jonsson J R et al.. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology. 2009; 136 2334-2344
44 Debernardi-Venon W, Martini S, Biasi F et al.. AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers. J Hepatol. 2007; 46 1026-1033
45 Friedman S L, Bansal M B. Reversal of hepatic fibrosis—fact or fantasy?. Hepatology. 2006; 43(2 Suppl 1) S82-S88
46 Gieling R G, Burt A D, Mann D A. Fibrosis and cirrhosis reversibility—molecular mechanisms. Clin Liver Dis. 2008; 12 915-937 xi
47 Pinzani M, Vizzutti F. Fibrosis and cirrhosis reversibility: clinical features and implications. Clin Liver Dis. 2008; 12 901-913 x
48 Yavrom S, Chen L, Xiong S, Wang J, Rippe R A, Tsukamoto H. Peroxisome proliferator-activated receptor gamma suppresses proximal alpha1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells. J Biol Chem. 2005; 280 40650-40659
49 Galli A, Crabb D W, Ceni E et al.. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology. 2002; 122 1924-1940
50 Botla R, Spivey J R, Aguilar H, Bronk S F, Gores G J. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J Pharmacol Exp Ther. 1995; 272 930-938
51 Pockros P J, Schiff E R, Shiffman M L et al.. Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C. Hepatology. 2007; 46 324-329

Wajahat MehalM.D. D.Phil.

Section of Digestive Diseases, Yale University

333 Cedar Street/1080 LMP, P.O. Box 208019, New Haven, CT 06520-8019

Email: Wajahat.mehal@yale.edu